TwinStrand Biosciences discusses Duplex Sequencing I AACR 2019

Jesse Salk, MD, PhD, Co-Founder, CEO, TwinStrand Biosciences Duplex Sequencing is an NGS error-correction method which increases accuracy by more than 10,000-fold and enables high-confidence detection of ultra-rare mutations. Here we present applications of Duplex Sequencing in early cancer detection, monitoring for residual disease, evolution of drug resistance and cancer risk assessment of new drugs and chemicals.

watch Webinar